Enterprise value:
$1.71B+$32.52M(+1.94%)Summary
- As of today (July 3, 2025), RXRX enterprise value is $1.71 billion, with a rise of +$32.52 million (+1.94%) during the most recent trading session on July 2, 2025.
- Over the past year, RXRX enterprise value has increased by +$83.70 million (+5.15%).
- RXRX enterprise value is now -73.04% below its all-time high of $6.34 billion.
Performance
RXRX Enterprise value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Enterprise value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
RXRX Enterprise value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | +1.9% | +1.6% | +1.6% |
| 1 m1 month | +24.9% | +19.2% | +19.2% |
| 3 m3 months | -1.7% | -1.4% | -1.5% |
| 6 m6 months | -27.9% | -25.9% | -27.7% |
| ytdytd | -22.1% | -21.0% | -22.9% |
| 1 y1 year | +5.2% | +5.3% | -27.2% |
| 5 y5 years | - | - | - |
RXRX Enterprise value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | $1.82B | -6.2% | $1.37B | +24.9% |
| 3 m | 3-month | $1.97B | -13.1% | $1.20B | +42.0% |
| 6 m | 6-month | $3.88B | -56.0% | $1.20B | +42.0% |
| 1 y | 1-year | $3.88B | -56.0% | $1.20B | +42.0% |
| 3 y | 3-year | $3.88B | -56.0% | $461M | +271.1% |
| 5 y | 5-year | $6.34B | -73.0% | $411M | +316.0% |
| alltime | all time | $6.34B | -73.0% | $411M | +316.0% |
RXRX Enterprise value History
| Date | Value |
|---|---|
| 2025 | $1.71B(-22.1%) |
| 2024 | $2.19B(+10.0%) |
| Date | Value |
|---|---|
| 2023 | $1.99B(+113.6%) |
| 2022 | $933.76M(-64.7%) |
| 2021 | $2.64B |
FAQ
- What is Recursion Pharmaceuticals enterprise value?
- What is the all time high enterprise value for Recursion Pharmaceuticals?
- What is RXRX enterprise value year-to-date change?
- What is Recursion Pharmaceuticals enterprise value year-on-year change?
What is Recursion Pharmaceuticals enterprise value?
The current enterprise value of RXRX is $1.71B
What is the all time high enterprise value for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high enterprise value is $6.34B
What is RXRX enterprise value year-to-date change?
Recursion Pharmaceuticals enterprise value has changed by -$484.22M (-22.07%) since the beginning of the year
What is Recursion Pharmaceuticals enterprise value year-on-year change?
Over the past year, RXRX enterprise value has changed by +$83.70M (+5.15%)